Related Experiment Video

Updated: Apr 29, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

5.7K

Structural basis for RKIP binding with its substrate Raf1 kinase

Zhihua Wu1, Cuiping Fu, Lina Shi

  • 1Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, 422 Siming South Road, Xiamen, 361005, Fujian, China, wuzhihua890320@163.com.

Biotechnology Letters
|May 28, 2014
PubMed

Insights

Raf1 kinase inhibitor protein (RKIP) binds to human Raf1 kinase, revealing key structural details. This discovery offers insights for developing drugs that disrupt this interaction, potentially impacting cancer treatment.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Biochemistry

Background:

  • Raf1 kinase inhibitor protein (RKIP) is a negative regulator of the Raf1/MEK/ERK pathway, crucial for cell growth and differentiation.
  • RKIP serves as a biomarker in clinical cancer diagnosis, and its interaction with Raf1 is vital but structurally uncharacterized.

Purpose of the Study:

  • To elucidate the structural basis of the interaction between human RKIP (hRKIP) and the N-terminus of human Raf1 kinase (hRaf11-147aa).
  • To identify key residues and structural elements involved in hRKIP-hRaf1 binding.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) experiments were employed to study the binding interaction.
  • Site-directed mutagenesis and binding affinity measurements (dissociation constant, Kd) were used to verify key residues and fragments.

Main Results:

  • hRKIP binds to the ligand-binding pocket, loop "127-149", and C-terminal helix of hRaf11-147aa.
  • Specific residues (D70, D72, E83, Y120, Y181) and the G143-R146 fragment of hRaf1 were identified as critical for hRKIP binding.
  • Deletion of the G143-R146 fragment significantly reduced binding affinity by approximately 300-fold.

Conclusions:

  • The study provides crucial structural insights into the hRKIP-hRaf1 interaction.
  • These findings can guide the design of novel therapeutic compounds aimed at disrupting this interaction for potential cancer therapy applications.

More Related Videos

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells06:44

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

1.9K
Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

10.3K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K